NRXP ▼ -1.5% - NRx Pharmaceuticals, Inc. $NRXP - NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine 15-OCT-2026 08:27 AM ET